Ali Rasheed Hameed AL Samarrai , Wijdan I. A. Abd-alwahab and Bakr Mohammed Mahdi
الملخص الانجليزي
This study aims to assess the hearing in patients with diabetes mellitus and hyperlipidemia. It includes 100
samples, which are distributed to four equal groups. The first group is control group (c), the second group is a diabetic patient
(G1), third group is hyperlipidemia patient (G2) and fourth group is patient with diabetes mellitus and hyperlipidemia (G3).
Glucose and lipid levels calculated according to the enzymatic method. The hearing threshold is measuring by pure tone
audiometry (PTA) after examination of ear canals and tympanic membranes and after we did tympanometry to exclude patients
with conductive hearing loss. The results revealed that there is an increase in the levels of glucose in G1 and G3 groups
compared to C and G2 groups, increasing of hearing impairment in the three deceased groups of compared to the healthy group.
The result showed increasing in levels of blood lipid profile (except HDL) in hyperlipidemia group and group of diabetes and
hyperlipidemia compared to the healthy group. Conclude from the study that hearing loss is more prevalent in patients with
diabetes mellitus and hyperlipidemia compared to patients with diabetes mellitus or hyperlipidemia. Alone high blood lipids may
lead to blood vessel dysfunction, injury or hearing loss. Hearing loss at different frequencies (low, medium and high) was
.observed in people with diabetes
وجدان ابراهيم عباس عبدالوهاب | Wijdan I. A. Abd-alwahab | 7274